Cypherpunk Technologies (CYPH) vs Faeth Therapeutics (FTH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Faeth Therapeutics (FTH) has outperformed Cypherpunk Technologies (CYPH) over the past year, losing 9.6% versus a loss of 38.2%. Over five years, CYPH leads with a -94.4% price change compared with -95.0% for FTH. Cypherpunk Technologies is the larger company by market cap ($210.1 million vs $203.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CYPH | FTH |
|---|---|---|
| Share price | $1.41 | $7.88 |
| Market cap | $210.15M | $203.65M |
| 1-day change | -18.02% | -9.32% |
| YTD return | +21.55% | -26.15% |
| 1-year return | -38.16% | -9.64% |
| 5-year return | -94.45% | -94.96% |
| P/E ratio (TTM) | 0.67 | — |
| EPS (TTM) | $2.09 | $-22.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $4.82M | $-21.09M |
| 52-week high | $4.19 | $42.14 |
| 52-week low | $0.491 | $7.45 |
| Distance from 52-week high | -66.35% | -81.30% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +254.61% | +612.56% |
| Average volume | 15.42M | 500.25K |
| Shares outstanding | 149.04M | 25.84M |
| Employees | 6 | 29 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FTH has outperformed CYPH by 28.5 percentage points over the past year.
About Cypherpunk Technologies
CYPH stock →Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Faeth Therapeutics
FTH stock →Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 29 employees
CYPH vs FTH FAQ
Which is bigger, Cypherpunk Technologies or Faeth Therapeutics?
Cypherpunk Technologies (CYPH) is larger, with a market capitalization of $210.15M compared with $203.65M for Faeth Therapeutics (FTH).
Which stock has performed better over the past year, CYPH or FTH?
FTH returned -9.64% over the past 12 months, compared with -38.16% for CYPH (price return, excluding dividends). Past performance does not predict future results.
Are Cypherpunk Technologies and Faeth Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.